Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging
暂无分享,去创建一个
Mircea Ariel Schoenfeld | Michael Sailer | Thomas Peschel | Thomas Eckert | Hans-Jochen Heinze | Nils Bodammer | Joern Kaufmann | Christoph Schrader | M. Schoenfeld | H. Heinze | M. Sailer | N. Bodammer | C. Schrader | T. Peschel | T. Eckert | J. Kaufmann
[1] L. Golbe,et al. Prevalence and natural history of progressive supranuclear palsy , 1988, Neurology.
[2] Shozo Tobimatsu,et al. Cerebral metabolic changes in early multiple system atrophy: a PET study , 2002, Journal of the Neurological Sciences.
[3] J. Rademacher,et al. Measuringin VivoMyelination of Human White Matter Fiber Tracts with Magnetization Transfer MR , 1999, NeuroImage.
[4] David J. Brooks,et al. A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson’s disease , 2001, Neurology.
[5] A. Benabid,et al. Opposite motor effects of pallidal stimulation in Parkinson's disease , 1998, Annals of neurology.
[6] Brian Ross. Basic Physics of MRS , 1999 .
[7] I. Shoulson,et al. Experimental therapeutics of neurodegenerative disorders: unmet needs. , 1998, Science.
[8] Brian D. Ross,et al. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases , 1999 .
[9] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[10] S. Nakamura,et al. Apparent diffusion coefficient measurements in progressive supranuclear palsy , 2000, Neuroradiology.
[11] J R Moeller,et al. Early differential diagnosis of Parkinson's disease with 18F‐fluorodeoxyglucose and positron emission tomography , 1995, Neurology.
[12] F. Barkhof,et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.
[13] M Hutchinson,et al. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. , 2000, AJNR. American journal of neuroradiology.
[14] Yulin Ge,et al. Age-related total gray matter and white matter changes in normal adult brain. Part II: quantitative magnetization transfer ratio histogram analysis. , 2002, AJNR. American journal of neuroradiology.
[15] Tetsuya Mori,et al. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration , 2002, Journal of the Neurological Sciences.
[16] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[17] F Federico,et al. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[18] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[19] M. Hallett,et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[20] Eileen O. Smith,et al. Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease , 1995, Annals of neurology.
[21] C. Marsden,et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.
[22] C D Marsden,et al. Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Annals of neurology.
[23] R. Balaban,et al. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.
[24] C. Good,et al. Differentiation of atypical parkinsonian syndromes with routine MRI , 2000, Neurology.
[25] Johannes Schwarz,et al. Steele‐Richardson‐Olszewski‐Syndrome: Reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: 123IBZM SPECT and MRI study , 2002, Movement disorders : official journal of the Movement Disorder Society.
[26] Irene Litvan,et al. Progressive supranuclear palsy : clinical and research approaches , 1992 .
[27] M. Pui,et al. Magnetization transfer analysis of brain tumor, infection, and infarction , 2000, Journal of magnetic resonance imaging : JMRI.
[28] J. Jankovic,et al. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy , 1998, Journal of Neural Transmission.
[29] R I Grossman,et al. Dyke Award paper. MR of wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. , 1994, AJNR. American journal of neuroradiology.
[30] M. Muenter,et al. Multi‐center study of Parkinson mortality with early versus later dopa treatment , 1987, Annals of neurology.
[31] H. Hanyu,et al. Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy , 2001, Neuroradiology.
[32] V. Dhawan,et al. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET , 1998, Movement disorders : official journal of the Movement Disorder Society.
[33] M Rovaris,et al. Correlations Between Clinical Findings and Magnetization Transfer Imaging Metrics of Tissue Damage in Individuals With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy , 2001, Stroke.
[34] R I Grossman,et al. Magnetization transfer imaging in the detection of injury associated with mild head trauma. , 2000, AJNR. American journal of neuroradiology.
[35] I Litvan,et al. Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.
[36] W. Heiss,et al. Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.
[37] R E Lenkinski,et al. Magnetization transfer imaging of diffuse axonal injury following experimental brain injury in the pig: characterization by magnetization transfer ratio with histopathologic correlation. , 1996, Journal of computer assisted tomography.
[38] Francesco Federico,et al. Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders , 1997 .
[39] N. Quinn,et al. Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.
[40] A Benazzouz,et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. , 1995, AJNR. American journal of neuroradiology.
[41] C. Manelfe,et al. Diffusion- and magnetisation transfer-weighted MRI in childhood moya-moya , 1998, Neuroradiology.
[42] A. Lees,et al. A clinicopathologic study of 100 cases of Parkinson's disease. , 1993, Archives of neurology.
[43] D. Margouleff,et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease , 1993, Annals of neurology.
[44] M Filippi,et al. Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.
[45] I Litvan,et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. , 1997, Archives of neurology.
[46] N. Schuff,et al. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[47] G. Barker,et al. Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.
[48] J. Mazziotta,et al. MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.
[49] C Kremser,et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.
[50] C Kremser,et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD , 2002, Neurology.
[51] Shigenobu Nakamura,et al. Magnetization Transfer Measurements of Brain Structures in Patients with Multiple System Atrophy , 2002, NeuroImage.
[52] I Litvan,et al. Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.
[53] M. Skalej,et al. Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.
[54] P. R. Hof,et al. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: A quantitative analysis of six cases , 2004, Acta Neuropathologica.
[55] Richard S. J. Frackowiak,et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography , 1992, Annals of neurology.
[56] Björn Gustavii,et al. Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease , 1997, Annals of neurology.
[57] W. M. van der Flier,et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease , 2002, Annals of neurology.
[58] Daniela Berg,et al. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings , 2001, Journal of Neurology.
[59] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[60] G J Barker,et al. Magnetisation transfer ratio of normal brain white matter: a normative database spanning four decades of life. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[61] Y Agid,et al. Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. , 1985, Brain : a journal of neurology.